# Hikma Farmaceutica, (Portugal) S.A. - Inspection Records

Source: https://www.keypedia.com/companies/hikma-farmaceutica-portugal-sa/39ec9f09-5b00-4a12-aa9b-2add04e825e0

> Inspection records and compliance data for Hikma Farmaceutica, (Portugal) S.A. in Terrugem Snt, None. Access full analysis and detailed observations.

---

## Details

- Name: Hikma Farmaceutica, (Portugal) S.A.
- FEI Number: 3002807173
- City: Terrugem Snt
- State: None
- Country Name: Portugal
- Address Line 1: Estrada Do Rio Da Mo
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [483 - Hikma Farmaceutica, (Portugal) S.A. - 2023-04-21](https://www.keypedia.com/records/483/hikma-farmaceutica-portugal-sa/01ca53ba-9078-481a-b252-e92fcebc2e0d) — source: FDA, date: April 21, 2023
- [FDA Inspection 1203129 - Hikma Farmaceutica, (Portugal) S.A. - 2023-04-21](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/953b74ba-98e1-45b9-9469-1a1f573c62c3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2023
- [FDA Inspection 1254066 - Hikma Farmaceutica, (Portugal) S.A. - 2023-02-03](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/d91e1295-3c57-4331-802a-b0cede79ffdb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 3, 2023
- [FDA Inspection 1125050 - Hikma Farmaceutica, (Portugal) S.A. - 2020-03-06](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/e42a8e89-092c-4ec6-98b4-778449084897) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 6, 2020
- [FDA Inspection 1050480 - Hikma Farmaceutica, (Portugal) S.A. - 2018-03-22](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/48513b65-9dd0-49c4-9472-e75c881a12c6) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2018
- [FDA Inspection 970483 - Hikma Farmaceutica, (Portugal) S.A. - 2016-04-12](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/750ebd04-5b32-41e5-8095-aeb25581c228) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 12, 2016
- [FDA Inspection 940389 - Hikma Farmaceutica, (Portugal) S.A. - 2015-06-19](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/bbb9b354-9549-4613-bd37-f19d03ce4f52) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2015
- [WARNING_LETTER - Hikma Farmaceutica, (Portugal) S.A. - 2014-03-28](https://www.keypedia.com/records/warning_letter/hikma-farmaceutica-portugal-sa/1a434d31-fc9b-40cf-b817-dd4d3436ca9c) — source: FDA, date: March 28, 2014
- [FDA Inspection 876911 - Hikma Farmaceutica, (Portugal) S.A. - 2014-03-28](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/a113812b-5fcb-419f-bfff-22950e15d221) — classification: Official Action Indicated (OAI), source: FDA, date: March 28, 2014
- [FDA Inspection 749882 - Hikma Farmaceutica, (Portugal) S.A. - 2011-09-29](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/a1bbb439-874a-4941-b003-b45bebeeb65d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2011
- [FDA Inspection 622473 - Hikma Farmaceutica, (Portugal) S.A. - 2009-09-24](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/fac01235-0751-41a5-8c58-5d97fb3294f2) — classification: No Action Indicated (NAI), source: FDA, date: September 24, 2009

## Related Companies

- [Teva Puerto Rico LLC](https://www.keypedia.com/companies/teva-puerto-rico-llc/1ed3f946-be5e-473a-ae76-ac9abcde2d21)
- [AbbVie Ltd](https://www.keypedia.com/companies/abbvie-ltd/b07cdd9b-e7d5-4b8b-b31d-3cc5dd0c3775)
- [Liebel-Flarsheim Company LLC](https://www.keypedia.com/companies/liebel-flarsheim-company-llc/ca074473-a6a3-413d-828a-bee4671e7f97)
- [Fareva Amboise](https://www.keypedia.com/companies/fareva-amboise/4d8ebbcc-2e13-4584-b144-63aa8191bc92)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/b3d7bba7-bfc8-4d2b-a517-321f7b518a12)
- [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [Finish Line Horse Products, Inc.](https://www.keypedia.com/companies/finish-line-horse-products-inc/205e6869-8995-4e35-9af4-e022b2dedb77)
- [Glaukos Corporation](https://www.keypedia.com/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83)
- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)

## Related Officers

- [Consumer safety Officer ](https://www.keypedia.com/people/maan-abduldayem/519ae250-d6ff-4412-afc7-49ae7ad6d002)
- [Thomas J. Cosgrove](https://www.keypedia.com/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)
- [Jose M. Cayuela](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
